|Series||World Health Organization. Technical report series -- no. 234, Technical report series (World Health Organization) -- 234.|
|The Physical Object|
|Pagination||48 p. :|
|Number of Pages||48|
Expert Committee on Trachoma: WHO TRS N° When autocomplete results are available use up and down arrows to review and enter to select. The World Health Organization Expert Committee is comprised of experts, including some of the most famous ophthalmologists in the world. Their Second Report should be read in entirety by those intimately concerned with the problems presented by trachoma. This report underlines certain outstanding difficulties, notably the fact that the causative agent has yet to be successfully propagated in. The Third Report of the WHO Expert Committee on Trachoma is a comprehensive and authoritative work. It does not, however, lend itself to abstraction but should be consulted in the original by those interested in the problem. All aspects of trachoma work are dealt with and there is considerable emphasis on the practical application of recent advances in basic research to the problems of trachoma. WHO Expert Committee on Trachoma & World Health Organization. (). Expert Committee on Trachoma: first report [of a meeting held in Geneva from 3 to 8 March ].
Abstract: This report contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the World Health Organization. It contains chapters on the chemotherapy of trachoma trachoma Subject Category: Diseases, Disorders, and Symptoms see more details; methods of trachoma control applicable in under-developed countries. 1. Rev Int Trach. ;29(4) [Expert Committee on Trachoma of the World Health Organization]. [Article in Undetermined Language] [No authors listed]. ITI’s Trachoma Expert Committee (TEC) is an independent body of internationally recognized experts that meets twice annually to review country applications for donations of Zithromax®. TEC members provide invaluable advice to ITI on strategic, technical, and operational issues. David Addiss, M.D., M.P.H. Generate and provide access to data and knowledge about trachoma for the global programme. ITI Performance Metrics in Zithromax® Shipments. CUMULATIVE TREATMENTS SHIPPED –Present. 22nd Trachoma Expert Committee Meeting. See All News and Resources. Follow Us On Social Media. About. ITI is a program of The Task Force for Global.
JECFA is an international scientific expert committee administered jointly by the Food and Agriculture Organization of the United Nations (FAO) and WHO. It has been meeting since , to evaluate the safety of food additives, contaminants, naturally occurring toxicants and residues of . Impor tant factors in such rational chemotherapy of trachoma are the choice of the drug, the form in which it is prepared, its route of ad ministration, the frequency of its applica tion, and the treatment schedule to be followed. REFERENCES 1. WHO: Expert Committee on Trachoma, Third Report. Geneva, WHO Technical Report, 2. 21st Trachoma Expert Committee Meeting. J Blog Post. 20th Trachoma Expert Committee Meeting. Decem Blog Post. 19th Trachoma Expert Committee Meeting in Muscat, Oman. Octo Blog Post. 2nd Annual RAFET Meeting. Septem Blog Post. 2nd Annual Southern Africa Meeting. Trachoma is a bacterial eye disease associated with socioeconomic factors including overcrowding and poor community hygiene. 70 Classification of trachoma is via the World Health Organization (WHO) simplified trachoma grading system. Active trachoma (defined as trachoma follicular and/or trachoma inflammation) predominantly affects young children, and is a contagious infection of the eye by.